Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4. - Test2 - elhamkhani - TriplyDB

Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4.

Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4.

http://www.wikidata.org/entity/Q34539750

about

Steroid hormones, steroid receptors, and breast cancer stem cells The role of miR-29b in cancer: regulation, function, and signaling MicroRNA regulation of progesterone receptor in breast cancer Epithelial-to-mesenchymal transition and the cancer stem cell phenotype: insights from cancer biology with therapeutic implications for colorectal cancer.Suppressive role exerted by microRNA-29b-1-5p in triple negative breast cancer through SPIN1 regulation.Natural and synthetic progestins enrich cancer stem cell-like cells in hormone-responsive human breast cancer cell populations in vitro.A novel role of Krüppel-like factor 4 in Zhikong scallop Chlamys farreri during spermatogenesis.The inhibitory role of Mir-29 in growth of breast cancer cells Overexpression of microRNA-200c predicts poor outcome in patients with PR-negative breast cancer.Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications.Generation of breast cancer stem cells by steroid hormones in irradiated human mammary cell lines Progesterone action in breast, uterine, and ovarian cancers.ADAM12-L is a direct target of the miR-29 and miR-200 families in breast cancer.Progesterone downregulation of miR-141 contributes to expansion of stem-like breast cancer cells through maintenance of progesterone receptor and Stat5a.A systems biology approach identifies a regulatory network in parotid acinar cell terminal differentiation.Disruption of miR-29 Leads to Aberrant Differentiation of Smooth Muscle Cells Selectively Associated with Distal Lung Vasculature.Krüppel-like Factor 4 Promotes Esophageal Squamous Cell Carcinoma Differentiation by Up-regulating Keratin 13 Expression Correlative Analysis of miRNA Expression and Oncotype Dx Recurrence Score in Estrogen Receptor Positive Breast Carcinomas Luteolin inhibits progestin-dependent angiogenesis, stem cell-like characteristics, and growth of human breast cancer xenografts.Fucoidan Elevates MicroRNA-29b to Regulate DNMT3B-MTSS1 Axis and Inhibit EMT in Human Hepatocellular Carcinoma Cells MicroRNA-29b/Tet1 regulatory axis epigenetically modulates mesendoderm differentiation in mouse embryonic stem cells.Cross disease analysis of co-functional microRNA pairs on a reconstructed network of disease-gene-microRNA tripartite.Progesterone-inducible cytokeratin 5-positive cells in luminal breast cancer exhibit progenitor properties.Steroid induction of therapy-resistant cytokeratin-5-positive cells in estrogen receptor-positive breast cancer through a BCL6-dependent mechanism.Toll-like receptor 3 (TLR3) activation induces microRNA-dependent reexpression of functional RARβ and tumor regression.Exploring and exploiting the fundamental role of microRNAs in tumor pathogenesis.microRNA-mediated regulation of the tumor microenvironment.Brown Seaweed Fucoidan Inhibits Cancer Progression by Dual Regulation of mir-29c/ADAM12 and miR-17-5p/PTEN Axes in Human Breast Cancer Cells.Lysine methylation of progesterone receptor at activation function 1 regulates both ligand-independent activity and ligand sensitivity of the receptor.Role of 3'-untranslated region translational control in cancer development, diagnostics and treatment.Induced cancer stem cells generated by radiochemotherapy and their therapeutic implications.MicroRNAs and the cancer phenotype: profiling, signatures and clinical implications.MicroRNAs in human lung cancer.Recurrence and metastasis of breast cancer is influenced by ovarian hormone's effect on breast cancer stem cells.Impact of progesterone on stem/progenitor cells in the human breast.Progesterone stimulates progenitor cells in normal human breast and breast cancer cells.Downregulation of miR-29 contributes to cisplatin resistance of ovarian cancer cells.Evaluation of miR-29c inhibits endotheliocyte migration and angiogenesis of human endothelial cells by suppressing the insulin like growth factor 1 The MicroRNA 29 Family Promotes Type II Cell Differentiation in Developing Lung.MicroRNAs, a subpopulation of regulators, are involved in breast cancer progression through regulating breast cancer stem cells.

P2860

Q26799113-E89272B2-1245-440A-B3C5-2F975F8E0894 Q26851543-C1F1C789-C55E-4C4F-B197-9395C966CBB7 Q33688484-714E01D7-70AC-4272-BFF9-5CF97C77C97B Q33700204-4381A0CD-B398-433E-90FC-65FD068E3900 Q33709960-6BEF1545-D3C6-4599-BF2D-85F8D4D88D09 Q33734466-21363B06-3451-4920-8CFA-7628A333E4C4 Q33860293-5ED7F422-460A-4D6F-8C18-D678985B28EA Q34249355-3C771755-1349-4424-A9D0-3138A275A623 Q34351474-360DD9E7-49AB-4930-8559-6906087849BA Q34437666-4F6295A1-1809-493F-A692-9711ECDF2844 Q35023058-0873C207-ECD6-4F22-BF18-9F8E8A0F279C Q35108906-87994F25-A3D4-4534-9AD5-ADFDE0E78C09 Q35155403-91A1CC85-FB4F-4BF9-AFC8-AE9A1A11DDDC Q35205643-2CCF8593-7D18-46E9-B18D-AAAA4C94B557 Q35558439-2D9F7086-657F-4A9F-94F2-01F5610D2C5A Q35644474-DF39B6CD-4A88-46EB-9BAE-8116FDB37834 Q35861040-1C843DBB-DC0F-42EB-98D7-49D8AB5BBC27 Q35881998-F67B9527-BF39-4D57-B221-1EEF8D102B96 Q35986434-46280F99-590D-4CE5-9F4D-A5EB56C0CE26 Q36226732-AF9AC36A-20F4-4979-BA0F-CD8A1346C669 Q36299130-0B87FCDC-D8D8-4487-9B46-5403C9DC1217 Q36322428-00CF950E-6D78-411A-A834-44984EBF30A5 Q36547484-B1202915-4844-4456-AA03-B6AE4377CC54 Q36707715-96174539-9798-4284-A977-3A421F223379 Q36932335-F72DA559-166E-431A-8DCD-D4A556288B85 Q37332728-F25A212A-4390-40F9-93D4-901A70724E2A Q37452957-2B2CF957-AE68-43F8-A39F-751A2293FC58 Q37514118-880AB218-A2EC-4251-B38D-5BF900799834 Q37608465-66ED0338-FB7F-49F9-AA72-C4AE8B8D3619 Q37617262-CC929A41-A674-4783-80B2-100D42113A33 Q37725612-EB2FEDA5-3EF6-40CB-8B85-6C9B2887771D Q38174308-30EC8FF7-585B-4896-BE93-7AED46F40F04 Q38215733-A2DAD1CB-6610-4B3B-AB0C-85D25F78C214 Q38373935-7775EAC6-6625-480B-8F14-42E58C416DE7 Q38562815-B1C79ECA-D00C-4939-9005-19095B0A78FF Q39036993-AC55F05F-633B-43FB-A46B-CFE3F170E561 Q39117322-BE784B81-664F-4223-BDAF-9E2DB61F9251 Q41298321-57B13956-B472-451E-87C1-B8A9C2762EDA Q41879546-AD378EB6-76B5-4B08-86A7-B2812FD6CE49 Q46752909-BCCEF02A-549E-40E2-964B-5514DA75FB5E

P2860

Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4.

http://www.wikidata.org/entity/Q34539750

description

2012 nî lūn-bûn

@nan

2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Progestin suppression of miR-2 ...... breast cancer cells via KLF4.

@ast

Progestin suppression of miR-2 ...... breast cancer cells via KLF4.

@en

Progestin suppression of miR-2 ...... breast cancer cells via KLF4.

@nl

type

label

Progestin suppression of miR-2 ...... breast cancer cells via KLF4.

@ast

Progestin suppression of miR-2 ...... breast cancer cells via KLF4.

@en

Progestin suppression of miR-2 ...... breast cancer cells via KLF4.

@nl

prefLabel

Progestin suppression of miR-2 ...... breast cancer cells via KLF4.

@ast

Progestin suppression of miR-2 ...... breast cancer cells via KLF4.

@en

Progestin suppression of miR-2 ...... breast cancer cells via KLF4.

@nl

P1433

Q34539750-C1D24BA7-4932-480D-BAAF-614FD5823A73

P1476

Q34539750-2213D0DB-C2D5-44A9-B5E0-8F2EDCF5CE09

P2093

Q34539750-0B5A76F2-2D6A-4B24-A4F6-01F5BBCADAE5

Q34539750-45DBA4A6-0F97-4B19-AB20-E8B360329950

Q34539750-6909D038-3962-442D-851E-17B5CE34630B

Q34539750-78BCCB96-F3BE-48D8-B1D4-FFAAF5352651

Q34539750-83878AA9-C35A-4F38-844D-E44F2F9D6DA8

Q34539750-8F49A004-5362-4312-A20E-00788574E4AD

Q34539750-B3D4779C-8DFC-442C-8F43-F1874AAF2515

P2860

Q34539750-024B1D11-FBD0-4324-BF69-8773FB6E7CDB

Q34539750-048A5DE9-6BFD-4106-B163-6DDD865D12D9

Q34539750-07632A92-6077-479B-8582-6E9D019162E2

Q34539750-09AD2867-CFDF-4C58-A1F2-AC44177F8148

Q34539750-0E66233D-C511-49C1-B25B-9BF36CF4C0FC

Q34539750-230470D4-EA52-452E-B438-C06162E0B5E1

Q34539750-25C23B45-8477-4615-A0E7-6C057450E01C

Q34539750-2A6C1386-624B-4884-91D2-C0D77FAA1CF2

Q34539750-2BF48C13-33B7-40E2-B23F-F8CD76DD3711

Q34539750-2E8650FC-328B-41CB-A2A7-248D8139C3EB

P2888

Q34539750-0B4C437A-BD8C-4798-8E27-032AA5A0AAA2

P304

Q34539750-881A474A-5788-44F3-9865-858CE4FB9BA5

P31

Q34539750-3E000439-4796-4AD0-AB45-4CFCB0EF54E2

P356

Q34539750-AA3AA23E-48C0-4910-B4EF-133C448B44DA

P407

Q34539750-5E60CAE3-56B0-4C53-B8FD-96CFB6C799DF

P433

Q34539750-E9B1F68A-0696-4711-AAFC-666FB0F273FB

P478

Q34539750-2CCBF8F0-2F3E-40D3-8DC0-939CD9AE0476

P50

Q34539750-09FEB93B-01AC-42AE-85EB-AB61FA32399D

Q34539750-7720580E-B6BF-4BC9-AD59-59E576095381

P577

Q34539750-70AD25C4-3DCC-4D2A-ADE9-3BD809E3E418

P6179

Q34539750-5EFCDD68-F778-4DF6-B45B-E6D9BA446E34

P698

Q34539750-A90F8FEA-F2DB-42DC-8FEF-9BC462705054

P932

Q34539750-56E22A3E-5DE3-43C8-B16E-5A7EE73DCD03

P356

P1433

P1476

Progestin suppression of miR-2 ...... f breast cancer cells via KLF4

@en

P2093

C A Sartorius

http://www.w3.org/2001/XMLSchema#string

E N Howe

http://www.w3.org/2001/XMLSchema#string

J Finlay-Schultz

http://www.w3.org/2001/XMLSchema#string

J K Richer

http://www.w3.org/2001/XMLSchema#string

N S Spoelstra

http://www.w3.org/2001/XMLSchema#string

P Hendricks

http://www.w3.org/2001/XMLSchema#string

S D Axlund

http://www.w3.org/2001/XMLSchema#string

P2860

Krüppel-like transcription factor 4 contributes to maintenance of telomerase activity in stem cells

MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B

Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer

The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype

Unique microRNA molecular profiles in lung cancer diagnosis and prognosis

MicroRNA gene expression deregulation in human breast cancer

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins.

Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181

P2888

P304

2555-2564

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/ONC.2012.275

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

Britta Jacobsen

Diana M Cittelly

P577

2012-07-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1012220098

http://www.w3.org/2001/XMLSchema#string

P698

22751119

http://www.w3.org/2001/XMLSchema#string

P932

4236860

http://www.w3.org/2001/XMLSchema#string